ITP: Tregs come to the rescue

Blood

Volumn 116, Issue 22, 2010, Pages 4388-4390

  Chong, Beng H ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD18 ANTIGEN; CD39 ANTIGEN; CELL PROTEIN; CYCLOSPORIN; CYTOKINE RECEPTOR AGONIST; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DANAZOL; DEXAMETHASONE; FIBRINOGEN RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE ACTIVATION GENE 3; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PERFORIN; RITUXIMAB; THROMBIN RECEPTOR; THROMBOPOIETIN RECEPTOR AGONIST; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; APOPTOSIS; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CYTOKINE RESPONSE; DRUG EFFECT; EFFECTOR CELL; HELPER CELL; HOMEOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOREGULATION; IMMUNOSURVEILLANCE; MACROPHAGE; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION; SPLENECTOMY; THROMBOCYTE COUNT; TREATMENT RESPONSE;

EID: 78649478749     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-302364     Document Type: Note

References (8)

1. Bao W, Bussel JB, Heck S, et al. Improved regulatory Tcell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood. 2010; 116(22):4639-4645.
2. Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326-336.
3. Andre S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity. Am J Pathol. 2009;174(5):1575-1587.
4. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial. Lancet. 2008;371(9610):395-403. (Pubitemid 351181334)
5. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007;357(22):2237- 2247.
6. Chong BH. Immune thrombocytopenia (ITP): understanding pathogenesis is the key to better treatments. J Thromb Haemostat. 2009;7(2):319-321.
7. Ling Y, Cao X, Yu Z, Ruan C. Circulating dendritic cell subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasone. Eur J Haematol. 2007; 79(4):310-316. (Pubitemid 47390130)
8. Stasi R, Cooper N, Del Poeta G, et al. Analysis of regulatory T-cell changes in patients with chronic immune thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood. 2008;122(4): 1147-1150.